Prevention Our most effective weapons are lockdowns, masks, distancing, ventilation and vaccination, but we can also protect close patient contacts pharmacologically. Subcutaneous REGEN-COV (Regeneron’s monoclonal antibody combo, casirivimab plus imdevimab) lowers the rate of illness by a whopping 81.4%. This has been known since April and blessed by the FDA in July, but has yet
A summary of state of the art COVID treatment originally appeared in KevinMD.com.